dtxcc.com | Digital Therapeutics | Digital Health | DTxCC

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.dtxcc.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Digital Therapeutics \| Digital Health \| DTxCC \| United
Description	DTxCC Provides Real-World, Hands-On Expertise in Digital Therapeutics & Digital Health DTX Commercialization Consultants is a Philadelphia based consultancy focused solely on Digital Therapeutics commercialization. Our services provide real-world, hands-on expertise in digital therapeutic & healthcare products. Contact DTxCC today for
Keywords	N/A

Server Information

WebSite	dtxcc.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

dtxcc.com Valuation

US$2,123

Last updated: 2023-05-20 08:50:16

dtxcc.com has Semrush global rank of 0. dtxcc.com has an estimated worth of US$ 2,123, based on its estimated Ads revenue. dtxcc.com receives approximately 244 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, dtxcc.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,123
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$58
Yearly Ads Revenue	US$705
Daily Unique Visitors	16
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
dtxcc.com.	A	3599	IP: 185.230.63.171
dtxcc.com.	A	3599	IP: 185.230.63.107
dtxcc.com.	A	3599	IP: 185.230.63.186
dtxcc.com.	NS	86400	NS Record: ns6.wixdns.net.
dtxcc.com.	NS	86400	NS Record: ns7.wixdns.net.
dtxcc.com.	MX	3600	MX Record: 30 alt2.aspmx.l.google.com.
dtxcc.com.	MX	3600	MX Record: 10 aspmx.l.google.com.
dtxcc.com.	MX	3600	MX Record: 40 alt3.aspmx.l.google.com.
dtxcc.com.	MX	3600	MX Record: 50 alt4.aspmx.l.google.com.
dtxcc.com.	MX	3600	MX Record: 20 alt1.aspmx.l.google.com.
dtxcc.com.	TXT	3600	TXT Record: google-site-verification=BCHSz4uf88q5xsk7t-vLP_S9KOWG4aEvqyoH19p1amM

HtmlToTextCheckTime:2023-05-20 08:50:16

top of page About Data Services Our Team Thought Leadership Advisory Council Case Studies Events DTxCC Gallery Contact Case Study Details News DIGITAL THERAPEUTICS COMMERCIALIZATION CONSULTANTS Strategy Development Backed by Research Introducing Health Data Consulting and Data Sourcing Learn More DTxCC Provides Real-World, Hands-On Expertise in Digital Therapeutics & Digital Health Products Specializing In Market Access Stakeholder Research Go-to-Market Strategy DTxCC provides guidance through each stage of business development, maximizing commercialization opportunities in digital therapeutics. Our team of expert consultants brings their deep digital therapeutics experience and supports end-to-end business planning by evaluating and creating a customized plan for your business. About Us Data Services Meet Our Team Advisory Council DTxCC Case Studies Digital Health Commercialization Digital Health Commercialization. DTxCC Case Study Go-to-Market Strategy Development Go-to-Market

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 28 Jan 2023 09:20:02 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.dtxcc.com/
strict-transport-security: max-age=3600
Age: 73293
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: yKskFaTI/RmB0yGOaMOo6Q==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi2l31Y5zFc6hhRNq4B3c0E,m0j2EEknGIVUW/liY8BLLsTmBPoSPlaywGXfZN3Xgj7JftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRallLyVXAJeYDNn2+VJkxygTuWvbRH0hJ/DAp2OKfC3JPJPYxsp1DUOE6ojO68ED3dDQ==,2UNV7KOq4oGjA5+PKsX47NkbCs7NWzOa7Lk4dAE/5sG8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1674897602.76762599558993461
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 28 Jan 2023 09:20:03 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1674897602.9171578901189418
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMdU2dumBKhu0CZVWGt/q/AG,qquldgcFrj2n046g4RNSVIrig9SAqnXW0O7zAzsQkQs=,2d58ifebGbosy5xc+FRalophsfvnfzmxLI81DnVAB1qbQZYSuSEJdIRjDOwBMliIGLC2TD/UgrnlY2mEQHTqyxto2UTyMzrxqUtKHm0zxsw=,2UNV7KOq4oGjA5+PKsX47CaoqenxK2HVw7LGKSkCvFdYgeUJqUXtid+86vZww+nL,7npGRUZHWOtWoP0Si3wDp7zT5RIk4Gbggt5/mHmXvRE=,xTu8fpDe3EKPsMR1jrheEC3nw6dBQjWVIHHCaSsZJ+0=,QCwmNx1TNUYLIqEqVA58OMTJqEEKJAhPzMfdfDutW/8ioqWVC5LoMhDvbQZCBwfSBFNjNRTmQgt5BwMmIVG00A==,xTu8fpDe3EKPsMR1jrheEC3nw6dBQjWVIHHCaSsZJ+0=,xTu8fpDe3EKPsMR1jrheENbSzrpZ8z9+e66vk2EFSCY=,LoUK8/saGAmOxZWtpubo2lxrdWwUAAagpaNvSH9pJohAP41BpLoCgIYopPFMHiHCoUDDuM0lSlWOA5oJGQLnQw==,xTu8fpDe3EKPsMR1jrheENbSzrpZ8z9+e66vk2EFSCY=,xTu8fpDe3EKPsMR1jrheECv0KB2FrMOWUy68k01tJoM=,/a5ccLSK1HEmwPNg/x6OukBp4TOQk+BVhxmhuz5i6pJqm5x0mVk1gkKLmJH+4Ep8qi+urAER3jsl9You0Lj+kw==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3_g; Max-Age=20; Expires=Sat, 28 Jan 2023 09:20:23 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

dtxcc.com valuation and analysis